Lista de obras -

A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers

artículo científico publicado en 2012

Abstract 3917: EMSY amplification and overexpression is not associated with defective homologous recombination and does not predict sensitivity to cisplatin or PARP inhibitors

article by Paul Wilkerson et al published 15 April 2011 in Cancer Research

Abstract 5076: Integrative genomic and transcriptomic analysis of metaplastic carcinomas of the breast

article by Alan G. Mackay et al published 15 April 2012 in Cancer Research

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

artículo científico publicado en 2014

Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study

artículo científico publicado en 2010

Functional characterization of EMSY gene amplification in human cancers

artículo científico publicado en 2011

Functional characterization of the 19q12 amplicon in grade III breast cancers

artículo científico publicado en 2012

Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection

artículo científico publicado en 2012

High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform

artículo científico publicado en 2011

Immunophenotypic and genomic characterization of papillary carcinomas of the breast

artículo científico publicado en 2011

Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast

scientific article published on 26 June 2014

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification

artículo científico publicado en 2015

Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer

artículo científico publicado en 2017

Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations

artículo científico publicado en 2013

Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer

artículo científico publicado en 2016

Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations

artículo científico publicado en 2011

Lista de obras de

A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers

Abstract 3917: EMSY amplification and overexpression is not associated with defective homologous recombination and does not predict sensitivity to cisplatin or PARP inhibitors

Abstract 5076: Integrative genomic and transcriptomic analysis of metaplastic carcinomas of the breast

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study

Functional characterization of EMSY gene amplification in human cancers

Functional characterization of the 19q12 amplicon in grade III breast cancers

Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection

High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform

Immunophenotypic and genomic characterization of papillary carcinomas of the breast

Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification

Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer

Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations

Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer

Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations